Potassium Channel Blockers and Openers as CNS Neurologic Therapeutic Agents

E-ISSN： 2212-3954|2|3|200-228

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.2, Iss.3, 2007-11, pp. : 200-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Window for Calcium-Channel Blockers in the Management of Dilated Cardiomyopathy: A Prospective, Two-Centre Study on Non-Advanced Disease

Cardiology, Vol. 117, Iss. 2, 2010-10 ,pp. : 148-154

Karger

Access to resources Recommend Favorite

Calcium Channel Blockers in Heart Failure

Cardiology, Vol. 89, Iss. 1, 1998-03 ,pp. : 38-46

Karger

Access to resources Recommend Favorite

Calcium‐Channel Blockers Attenuate the Antiplatelet Effect of Clopidogrel

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 33, Iss. 5, 2015-10 ,pp. : 264-269

John Wiley & Sons Inc

Access to resources Recommend Favorite

Are beta‐blockers on the therapeutic horizon for ovarian cancer treatment?

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3380-3383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transcription Factors as Therapeutic Targets in CNS Disorders

Recent Patents on CNS Drug Discovery, Vol. 4, Iss. 3, 2009-11 ,pp. : 190-199

Bentham Science Publishers

Access to resources Recommend Favorite